Synthory AI

Startup
Summarized by Halo AI

Synthory AI provides an AI-powered copilot for biomedical writing and systematic literature research, designed to help researchers and life science companies automate evidence synthesis and report generation.

Founded & HQ
Dover, DE, USA
Company size
1-10 employees
Activity highlights
Launched the claim verification feature inside its MS Word integrated biomedical research review platform in June 2025

Synthory AI has developed an interactive biomedical writing copilot designed to assist research teams with literature analysis and document generation. The platform leverages artificial intelligence to automate various aspects of the systematic review process, including evidence verification, data extraction, and the creation of PRISMA-aligned reports, summaries, tables, and diagrams. By integrating with established research databases, it aims to streamline the synthesis of scientific information and improve the efficiency of academic and clinical research workflows.

This tool is primarily intended for professionals in the pharmaceutical and MedTech industries, as well as academic researchers, helping them save significant time on evidence-based projects. By automating complex literature reviews, Synthory AI provides decision-support capabilities that allow users to generate updated datasets and structured reviews aligned with peer-reviewed standards. The service has been utilized for practical research applications, such as the synthesis of reviews on digital health interventions, demonstrating its utility in managing large volumes of scientific data for research and development purposes.

AI summary generated on Jun 22, 2026
OpenAlexOpenAlex

For general inquiries

AG
Artem Galeev
Chief Scientist
Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.